IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#3054
Positioning
Market Dominance
Manufacturing
Medical Equipment
$5.3B
Liam J. Kelly
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems. The company also offers interventional products, which consists of various coronary, structural heart therapies, and peripheral intervention and cardiac assist products.
Headcount
15.5K
HQ Base
Wayne, Pennsylvania
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = TFX ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$TFX TELEFLEX INC | 44 | 41 | 32 | 29 | - | 33.5x | -2.1% | -1.0% | 54.1% | 3.1% | -0.3% | 21.8% | 1.1% | 70.0x | $5.3B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
TELEFLEX INC (TFX) receives a "Reduce" rating with a composite score of 43.5/100. It ranks #3054 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Liam J. Kelly
Chief Executive Officer
Labor Force
15,500
41
42
71
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for TFX
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for TFX.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 41 | 18 | +23ALPHA |
| MOMENTUM | 29 | 8 | +21ALPHA |
| VALUATION | 32 | 12 | +20ALPHA |
| INVESTMENT | 42 | 77 | -35DRAG |
| STABILITY | 71 | 67 | +4NEUTRAL |
| SHORT INT | 48 | 46 | +2NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -13.9% vs WACC 6.7% (spread -20.7%)
GM 54% vs sector 43%, OM 3% vs sector 1%
Capital turnover 0.39x, R&D intensity 5.5%
Rev growth 22%, 10yr history
Interest coverage -12.8x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
TELEFLEX INC receives a Reduce rating from our analysis, with a composite score of 43.5/100 and 2 out of 5 stars, ranking #3054 out of 7,333 stocks. TFX's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
TFX's quality score of 41/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -2.1% (sector avg: -2.5%), gross margins of 54.1% (sector avg: 42.5%), net margins of -0.3% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
With a value score of 32/100, TFX appears somewhat expensive relative to its fundamentals. Key valuation metrics include an EV/EBITDA of 33.47x, a P/B ratio of 1.34x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
With an investment score of 42/100, TFX exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 21.8% vs. a sector average of 5.9% and a return on assets of -1.0% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
TELEFLEX INC is experiencing notably weak momentum with a score of just 29/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at 21.8% year-over-year, while a beta of 0.82 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
TFX shows good financial stability with a score of 71/100. Key stability metrics include a beta of 0.82 and a debt-to-equity ratio of 70.00x (sector avg: 0.2x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
The short interest score of 48/100 for TFX suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 70.00x). With a $5.3B market cap (mid-cap), TELEFLEX INC may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
TFX offers a modest dividend yield of 1.1%. While the income contribution is relatively small, even a small dividend signals management's commitment to shareholder returns and can serve as a signal of financial discipline.
TELEFLEX INC is a mid-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #3054 of 7,333 overall (58th percentile). Key comparisons include ROE of -2.1% exceeding the -2.5% sector median and operating margins of 3.1% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While TFX currently exhibits a REDUCE profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Momentum (29) would have the largest impact on the composite score.
EV/EBITDA 192% ABOVE SECTOR MEDIAN
ROE 15% BELOW SECTOR MEDIAN
Gross Margin 27% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 28, 2025 (Q2 FY2025)
We rate TELEFLEX INC (TFX) as a Reduce with a composite score of 43.5/100 at a current price of $112.13. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential and elevated risk of underperformance relative to peers over the next 12 months.
The rating is primarily driven by strength in stability (71th percentile) and investment (42th percentile), which together account for the majority of the composite score. Offsetting weakness in momentum (29th percentile) and value (32th percentile) tempers our overall conviction. We assign a No Moat rating (39/100), High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; sustainability of the current growth rate; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
TELEFLEX INC holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 43.5/100 places it at rank #3054 in our full 7,333-stock universe. At $5.3B in market capitalization, TELEFLEX INC is a mid-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 22%, though momentum at the 29th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 54% (+11.6pp vs sector) narrow to operating margins of 3% (+1.8pp vs sector) and net margins of -0.3%, yielding a gross-to-net conversion rate of -0%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $112.13, TELEFLEX INC is trading at a premium to fundamental value. Our value factor score of 32/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at EV/EBITDA of 33.5x (at a premium), P/B of 1.3x, P/S of 1.6x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 54% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 22% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
The Reduce rating (composite 43.5/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Thin net margins of -0.3% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (29th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
We assign a High uncertainty rating to TELEFLEX INC. Key risk factors include current negative profitability (net margin -0.3%), the combination of leverage (70% D/E) and thin margins (-0.3% net) amplifies downside risk. The wide range of potential outcomes widens our fair value estimate and increases the possibility of permanent capital impairment. Investors considering this name should size positions accordingly and demand a meaningful margin of safety before initiating.
Specific risk factors that inform our assessment include: current negative profitability (net margin -0.3%); the combination of leverage (70% D/E) and thin margins (-0.3% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 71th percentile and quality factor at the 41th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 54% provide a buffer against cost pressures; above-average stability (71th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate TELEFLEX INC's capital allocation as Poor. Key concerns include low returns on equity (-2.1%), negative profitability, weak asset returns (ROA -1.0%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — TELEFLEX INC significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, TELEFLEX INC receives a Reduce rating with a composite score of 43.5/100 (rank #3054 of 7,333). Our quantitative framework assigns a No Moat (39/100, trend: stable), High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 43/100.
Our analysis does not support a constructive view on TELEFLEX INC at this time. The combination of limited competitive advantages, high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign TELEFLEX INC a meaningful economic moat, scoring 39/100 on our composite assessment. The ROIC-WACC spread of -20.7% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 14.7/20.
The strongest moat sources are margin superiority (14.7/20) and growth durability (10.3/20). GM 54% vs sector 43%, OM 3% vs sector 1%. Rev growth 22%, 10yr history. These pillars form the core of TELEFLEX INC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (1.9/20) and economic value creation (4.2/20). Capital turnover 0.39x, R&D intensity 5.5%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect TELEFLEX INC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 54% providing a solid profitability foundation, robust top-line growth of 22% expanding the revenue base. The margin cascade from 54% gross to 3% operating to -0.3% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 41th percentile.
The margin profile shows gross margins of 54%, operating margins of 3%, net margins of -0.3%. Return metrics include ROE of -2.1% and ROA of -1.0%. Relative to the Manufacturing sector, gross margins are 11.6 percentage points above the sector median of 43%, and ROE of -2.1% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 70%, a dividend yield of 1.13%, revenue growth of 22%. The sector median D/E is 0%, putting TELEFLEX INC at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
NeuroPace (NPCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teleflex has completed its acquisition of BIOTRONIK's Vascular Intervention business for €760 million, expanding its global presence in the cath lab and peripheral intervention market with a comprehensive portfolio of medical technologies.
Teleflex announced it would host a conference call on February 26, 2026, to review its fourth-quarter 2025 results and provide an operational update, with live and replay audio available via the company’s website. This update comes soon after the abrupt departure of CEO Liam Kelly and the launch of a securities fraud investigation, raising fresh questions about governance and operational continuity. We’ll now examine how the CEO’s immediate departure and related securities fraud...
Amber Therapeutics’ new headquarters and state-of-art manufacturing facility at Harwell, near Oxford, UK. Picture courtesy of Amber Therapeutics. Oxford, UK – 24 February 2026 – Amber Therapeutics today announced a series of updates to its business highlighting the significant progress it has made since closing its $100 million (£80 million) Series A financing in July 2024—one of the largest Series A rounds ever raised by a European medical technology company. New appointees to Board and Leaders